FDA: Stephen Hahn
Stephen Hahn is expected to be nominated as commissioner of the US Food and Drug Administration by President Trump, the White House said on Nov. 1. Hahn has been the chief medical executive at the MD Anderson Cancer Center since 2018 and a professor of radiation oncology at MD Anderson since 2015. Previously, he was chair of the Department of Radiation Oncology at the University of Pennsylvania, and before that, he was a senior investigator at the National Cancer Institute. Hahn holds a medical degree from Temple University and a BA in biology from Rice University. Following his appointment, Ned Sharpless, current acting commissioner of the FDA, will return to his post as director of the NCI, and Doug Lowy, who took over for Sharpless, will return to be principal deputy director of the NCI.